Treatment received and treatment adequacy of depressive disorders among young adults in Finland

BMC Psychiatry

Jaana Suvisaari⁴  Samuli I Saarni¹  Jonna Perälä³  Terhi Aalto-Setälä²  Mauri Marttunen⁵  Teija Kasteenpohja³ 

[1] Turku University Hospital and University of Turku, Turku, Finland;The Social Insurance Institute, Helsinki, Finland;Department Health, Mental Health Unit, National Institute for Health and Welfare, Helsinki, 00271, Finland;Department of Social Psychiatry, Tampere School of Public Health, University of Tampere, Tampere, Finland;Adolescent Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

关键词: Young adults;    Treatment;    Depressive disorders;   

Others  :  1137827
DOI  :  10.1186/s12888-015-0427-8

 received in 2014-06-30, accepted in 2015-02-20,  发布年份 2015

【 摘 要 】

Background

Under-treated depression may be especially harmful in early adulthood. The aims of this study are to describe treatments received for depressive disorders, to define factors associated with treatment adequacy and dropouts from treatment in a Finnish general population sample of young adults.

Methods

A nationally representative two-stage cluster sample of 1894 Finns aged 19 to 34 years was sent a questionnaire containing several mental health screens. All screen positives and a random sample of screen negatives were invited to participate in a mental health assessment including a SCID interview. Case records from mental health treatments for the same sample were obtained for the final diagnostic assessment. Based on all available information, receiving antidepressant pharmacotherapy for at least two months with at least four visits with any type of physician or at least eight sessions of psychotherapy within 12 months or at least four days of hospitalization were regarded as minimally adequate treatment. Treatment dropout was rated if the treatment strategy was assessed to be adequate according to the case records but the patient discontinued the visits.

Results

Of participants with depressive disorders (n = 142), 40.9% received minimally adequate treatment. In multiple logistic regression models, substance use disorder and female gender were associated with at least one visit with a physician, while having major depressive disorder was associated with visits with a physician at least 4 times a year. Women had higher odds of having received any psychotherapy and psychotherapy lasting for at least 8 sessions in a year. Low education and a history of suicide attempt were associated with increased odds of treatment dropout. None of the factors explained the final outcome of minimally adequate treatment.

Conclusions

Treatment adequacy in the present study was better than previously seen, but more efforts are needed to provide adequate treatment for young adults, especially those with low education and suicidality.

【 授权许可】

   
2015 Kasteenpohja et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al.: Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 2013, 10(11):e1001547.
• [2]Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al.: Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004, 420:38-46.
• [3]Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al.: Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011, 21(10):718-79. doi:10.1016/j.euroneuro.2011.08.008
• [4]Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al.: The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011, 21(9):655-79. doi:10.1016/j.euroneuro.2011.07.018
• [5]Alonso J, Lepine JP: ESEMeD/MHEDEA 2000 Scientific Committee: Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry 2007, 68 Suppl 2:3-9.
• [6]Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al.: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289(23):3095-105.
• [7]Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, et al.: Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007, 370(9590):841-50.
• [8]Wittchen HU, Nelson CB, Lachner G: Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 1998, 28(1):109-26.
• [9]Kessler RC, Walters EE: Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 1998, 7(1):3-14.
• [10]Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):593-602. doi:10.1001/archpsyc.62.6.593
• [11]Newman DL, Moffitt TE, Caspi A, Magdol L, Silva PA, Stanton WR: Psychiatric disorder in a birth cohort of young adults: prevalence, comorbidity, clinical significance, and new case incidence from ages 11 to 21. J Consult Clin Psychol 1996, 64(3):552-62.
• [12]Aalto-Setälä T, Marttunen M, Tuulio-Henriksson A, Poikolainen K, Lönnqvist J: Psychiatric treatment seeking and psychosocial impairment among young adults with depression. J Affect Disord 2002, 70(1):35-47.
• [13]Haarasilta L, Marttunen M, Kaprio J, Aro H: Major depressive episode and health care use among adolescents and young adults. Soc Psychiatry Psychiatr Epidemiol 2003, 38(7):366-72.
• [14]Duhoux A, Fournier L, Nguyen CT, Roberge P, Beveridge R: Guideline concordance of treatment for depressive disorders in Canada. Soc Psychiatry Psychiatr Epidemiol 2009, 44(5):385-92.
• [15]Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, et al.: The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med 2007, 147(5):320-9.
• [16]Eisenberg D, Chung H: Adequacy of depression treatment among college students in the United States. Gen Hosp Psychiatry 2012, 34(3):213-20. doi: 10.1016/j.genhosppsych.2012.01.002
• [17]Melo AP, Guimarães MD: Factors associated with psychiatric treatment dropout in a mental health reference center, Belo Horizonte. Rev Bras Psiquiatr 2005, 27(2):113-8. doi:/S1516-44462005000200008
• [18]Olfson M, Mojtabai R, Sampson NA, Hwang I, Druss B, Wang PS, et al.: Dropout from outpatient mental health care in the United States. Psychiatr Serv 2009, 60(7):898-907. doi:10.1176/appi.ps.60.7.898
• [19]Pinto-Meza A, Fernández A, Bruffaerts R, Alonso J, Kovess V, De Graaf R, et al.: Dropping out of mental health treatment among patients with depression and anxiety by type of provider: results of the European Study of the Epidemiology of Mental Disorders. Soc Psychiatry Psychiatr Epidemiol 2011, 46(4):273-80. doi:10.1007/s00127-010-0195-1
• [20]Wang J: Mental health treatment dropout and its correlates in a general population sample. Med Care 2007, 45(3):224-9. doi:10.1097/01.mlr.0000244506.86885.a5
• [21]Killaspy H, Banerjee S, King M, Lloyd M: Prospective controlled study of psychiatric out-patient non-attendance. Characteristics and outcome. Br J Psychiatry 2000, 176:160-5.
• [22]Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET: Continuity is the main challenge in treating major depressive disorder in psychiatric care. J Clin Psychiatry 2005, 66(2):220-7.
• [23]Young AS, Grusky O, Jordan D, Belin TR: Routine outcome monitoring in a public mental health system: the impact of patients who leave care. Psychiatr Serv 2000, 51(1):85-91.
• [24]Suvisaari J, Aalto-Setälä T, Tuulio-Henriksson A, Härkänen T, Saarni SI, Perälä J, et al.: Mental disorders in young adulthood. Psychol Med 2009, 39(2):287-99. doi:10.1017/S0033291708003632
• [25]Aromaa A, Koskinen S: Kansanterveyslaitos: Health and functional capacity in Finland: baseline results of the Health 2000 health examination survey. National Public Health Institute, Helsinki; 2004.
• [26]Heistaro S: Kansanterveyslaitos: Methodology report: health 2000 survey. National Public Health Institute, Helsinki; 2008.
• [27]Pirkola SP, Isometsä E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, et al.: DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population–results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 2005, 40(1):1-10. doi:10.1007/s00127-005-0848-7
• [28]Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, et al.: Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003, 60(2):184-9.
• [29]Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, et al.: The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997, 27(1):191-7.
• [30]Morgan JF, Reid F, Lacey JH: The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ 1999, 319(7223):1467-8.
• [31]Wittchen HU, Lachner G, Wunderlich U, Pfister H: Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998, 33(11):568-78.
• [32]Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, et al.: Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry 2000, 157(11):1873-5.
• [33]Mayfield D, McLeod G, Hall P: The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974, 131(10):1121-3.
• [34]First MB, Spitzer RL, Gibbon M, Williams JBW: Structured clinical interview for DSM-IV-TR Axis I Disorders - Patient Edition (SCID I/P, 2/2001 Revision). Psychiatric Institute, Biometrics Reseach Department, New York State; 2001.
• [35]Kessler RC: The global burden of anxiety and mood disorders: putting the European Study of the Epidemiology of Mental Disorders (ESEMeD) findings into perspective. J Clin Psychiatry 2007, 68(Suppl 2):10-9.
• [36]Castaneda AE, Suvisaari J, Marttunen M, Perälä J, Saarni SI, Aalto-Setälä T, et al.: Cognitive functioning in a population-based sample of young adults with a history of non-psychotic unipolar depressive disorders without psychiatric comorbidity. J Affect Disord 2008, 110(1–2):36-45. doi:10.1016/j.jad.2007.12.239
• [37]American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th edn, text revision. American Psychiatric Association, Washington, DC; 2000.
• [38]American Psychiatric Association: Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association Am J Psychiatry 2000, 157(4 Suppl):1-45.
• [39]National Institute for Clinical Excellence. Management of depression in primary and secondary care. NICE; 2004. [http://www.nice.org.uk].
• [40]Fernández A, Haro JM, Martinez-Alonso M, Demyttenaere K, Brugha TS, Autonell J, et al.: Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry 2007, 190:172-3.
• [41]Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC: Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):629-40.
• [42]Suokas JT, Suominen K, Heilä H, Ostamo A, Aalto-Setälä T, Perälä J, et al.: Attempted suicide in mental disorders in young adulthood. Soc Psychiatry Psychiatr Epidemiol 2011, 46(10):965-74. doi:10.1007/s00127-010-0272-5
• [43]Hämäläinen J, Isometsä E, Sihvo S, Kiviruusu O, Pirkola S, Lönnqvist J: Treatment of major depressive disorder in the Finnish general population. Depress Anxiety 2009, 26(11):1049-59. doi:10.1002/da.20524
• [44]Simpson KR, Meadows GN, Frances AJ, Patten SB: Is mental health in the canadian population changing over time? Can J Psychiatry 2012, 57(5):324-31.
• [45]González HM, Vega WA, Williams DR, Tarraf W, West BT, Neighbors HW: Depression care in the United States: too little for too few. Arch Gen Psychiatry 2010, 67(1):37-46. doi:10.1001/archgenpsychiatry.2009.168
• [46]Wahlbeck K: European comparisons between mental health services. Epidemiol Psychiatr Sci 2011, 20(1):15-8.
• [47]Holma KM, Holma IA, Melartin TK, Rytsala HJ, Isometsa ET: Long-term outcome of major depressive disorder in psychiatric patients is variable. J Clin Psychiatry 2008, 69(2):196-205.
• [48]Riihimaki K, Vuorilehto M, Isometsa E: A 5-year prospective study of predictors for functional and work disability among primary care patients with depressive disorders. Eur Psychiatry 2015, 30(1):51-7.
• [49]Druss BG, Hoff RA, Rosenheck RA: Underuse of antidepressants in major depression : prevalence and correlates in a national sample of young adults. J Clin Psychiatry 2000, 61(3):234-7.
• [50]Hämäläinen J, Isometsä E, Laukkala T, Kaprio J, Poikolainen K, Heikkinen M, et al.: Use of health services for major depressive episode in Finland. J Affect Disord 2004, 79(1–3):105-12.
• [51]Lewinsohn PM, Clarke GN, Seeley JR, Rohde P: Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolescent Psychiatry 1994, 33(6):809.
• [52]Wang PS, Angermeyer M, Borges G, Bruffaerts R, Tat Chiu W, DE Girolamo G, et al.: Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry 2007, 6(3):177-85.
• [53]Lewinsohn PM, Rohde P, Seeley JR: Treatment of adolescent depression: frequency of services and impact on functioning in young adulthood. Depress Anxiety 1998, 7(1):47-52.
• [54]Wang PS, Berglund P, Kessler RC: Recent care of common mental disorders in the United States : prevalence and conformance with evidence-based recommendations. J Gen Intern Med 2000, 15(5):284-92.
• [55]Briffault X, Sapinho D, Villamaux M, Kovess V: Factors associated with use of psychotherapy. Soc Psychiatry Psychiatr Epidemiol 2008, 43(2):165-71. doi:10.1007/s00127-007-0281-1
• [56]Olfson M, Pincus HA: Outpatient psychotherapy in the United States, I: volume, costs, and user characteristics. Am J Psychiatry 1994, 151(9):1281-8.
• [57]Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al.: Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004, 420:47-54. doi:10.1111/j.1600-0047.2004.00330.x
• [58]Kessler RC, Brown RL, Broman CL: Sex differences in psychiatric help-seeking: evidence from four large-scale surveys. J Health Soc Behav 1981, 22(1):49-64.
• [59]Sihvo S, Wahlbeck K, McCallum A, Sevon T, Arffman M, Haukka J, et al.: Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population-based study from Finland. Pharmacoepidemiol Drug Saf 2010, 19(11):1186-93. doi:10.1002/pds.2017
• [60]O’Brien A, Fahmy R, Singh SP: Disengagement from mental health services. A literature review. Soc Psychiatry Psychiatr Epidemiol 2009, 44(7):558-68.
• [61]Wells JE, Oakley Browne M, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Angermeyer MC, et al.: Drop out from out-patient mental healthcare in the World Health Organization’s World Mental Health Survey initiative. Br J Psychiatry 2013, 202(1):42-9. doi:10.1192/bjp.bp.112.113134
• [62]Jenkins R, Lewis G, Bebbington P, Brugha T, Farrell M, Gill B, et al.: The National Psychiatric Morbidity surveys of Great Britain–initial findings from the household survey. Psychol Med 1997, 27(4):775-89.
• [63]Katzman MA, Anand L, Furtado M, Chokka P: Food for thought: understanding the value, variety and usage of management algorithms for major depressive disorder. Psychiatry Res 2014, 220S1:S3-14.